Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -25.89% vs -80.06% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -23.14% vs -84.55% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 0.00% vs 33.33% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Akero Therapeutics, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 0.28% vs -1.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -25.89% vs -80.06% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -3.72% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -23.14% vs -84.55% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs 33.33% in Jun 2024






